Is Scinai Immunotherapeutics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Scinai Immunotherapeutics Ltd (SCNI) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Scinai Immunotherapeutics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Scinai Immunotherapeutics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Scinai Immunotherapeutics Ltd?

Muslim investors may consider investing in Scinai Immunotherapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Scinai Immunotherapeutics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Scinai Immunotherapeutics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Scinai Immunotherapeutics Ltd updated?

The Shariah compliance status of Scinai Immunotherapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Scinai Immunotherapeutics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Scinai Immunotherapeutics Ltd?

You can check the latest Shariah compliance status of Scinai Immunotherapeutics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SCNI Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 29, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Scinai Immunotherapeutics Ltd (SCNI)

Based on 7 analysts giving stock ratings to Scinai Immunotherapeutics Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Scinai Immunotherapeutics Ltd. Stock Analysis SCNI

United States Health Care Nano Cap Report: 2025 Annual

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Key Statistics of Scinai Immunotherapeutics Ltd (SCNI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.50$0.57

Today's Open

$0.51

Volume

154.19K

P/E Ratio (TTM)

52 Week Range

$0.45$6.18

Market Cap

2.24M

Avg. Volume

8.99M

Dividend Yield

Financial Metrics & Statements of Scinai Immunotherapeutics Ltd (SCNI)

FAQ's for Scinai Immunotherapeutics Ltd (SCNI)

According to Musaffa’s Shariah screening methodology, Scinai Immunotherapeutics Ltd (SCNI) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.